Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mahmood Fadaie

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Research in Pharmaceutical Sciences|December 18, 2024
Novel SARS-COV2 poly epitope phage-based candidate vaccine and its immunogenicitySharareh Mohammad Hasani, Mahdi Behdani, Zohreh Amirkhani, et al.
Biochemical Genetics|November 11, 2025
Novel Frameshift Deletion Pathogenic Variant Characterization in Tuberous Sclerosis-2 Using Exome Sequencing and Molecular Dynamics SimulationMahmood Fadaie, Sajjad Biglari, Hassan Vahidnezhad, et al.
CNS & Neurological Disorders Drug Targets|February 24, 2022
Nanoparticles as Powerful Tools for Crossing the Blood-brain BarrierBehnam Hasannejad-Asl, Farkhondeh Pooresmaeil, Edris Choupani, et al.
Small Science|April 11, 2025
Exploring Advanced CRISPR Delivery Technologies for Therapeutic Genome EditingNeda Rostami, Mohammad Mahmoudi Gomari, Edris Choupani, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Research in Pharmaceutical Sciences|December 18, 2024
Novel SARS-COV2 poly epitope phage-based candidate vaccine and its immunogenicitySharareh Mohammad Hasani, Mahdi Behdani, Zohreh Amirkhani, et al.
Biochemical Genetics|November 11, 2025
Novel Frameshift Deletion Pathogenic Variant Characterization in Tuberous Sclerosis-2 Using Exome Sequencing and Molecular Dynamics SimulationMahmood Fadaie, Sajjad Biglari, Hassan Vahidnezhad, et al.
CNS & Neurological Disorders Drug Targets|February 24, 2022
Nanoparticles as Powerful Tools for Crossing the Blood-brain BarrierBehnam Hasannejad-Asl, Farkhondeh Pooresmaeil, Edris Choupani, et al.
Small Science|April 11, 2025
Exploring Advanced CRISPR Delivery Technologies for Therapeutic Genome EditingNeda Rostami, Mohammad Mahmoudi Gomari, Edris Choupani, et al.
Pageof 2